Invasive pneumococcal diseases in children and adolescents--a single centre experience

Area of Science:

• Pediatrics
• Infectious Diseases
• Vaccinology

Background:

• Streptococcus pneumoniae (S. pneumoniae) is a leading cause of pediatric meningitis, pneumonia, and sepsis.
• Universal pneumococcal vaccination for children under two was recommended in Germany in 2006.
• This study evaluated invasive pneumococcal disease (IPD) prevalence and outcomes before and after vaccine introduction.

Purpose of the Study:

• To compare the incidence and outcomes of IPD in children before and after the implementation of universal pneumococcal vaccination.
• To identify factors influencing IPD rates and outcomes in a pediatric population.

Main Methods:

• Retrospective analysis of 55 IPD cases over an 11-year period at a single hospital.
• Data collection included patient demographics, clinical presentation, complications, vaccination status, serotypes, and treatment.
• Comparison of IPD rates and outcomes pre- and post-vaccine introduction.

Main Results:

• IPD frequency did not decrease post-vaccination. Almost half of patients were under two years old.
• Pneumonia was the most common diagnosis, followed by meningitis and sepsis. 11% of cases resulted in death, and 11% had long-term complications.
• Only 31% of patients were vaccinated; common serotype was 14. High cephalosporin use (over 90%) prompted antibiotic stewardship.

Conclusions:

• The study did not observe a decrease in IPD frequency post-vaccination, suggesting potential issues with vaccine administration or awareness.
• Management of pre-existing conditions and rare deficiencies is critical, especially in severe IPD cases.
• High antibiotic use necessitates antibiotic stewardship initiatives.